LV10191A - Farmaceitiski lidzekli hepatita B virusa izraisito infekciju un slimibu arstesanai - Google Patents

Farmaceitiski lidzekli hepatita B virusa izraisito infekciju un slimibu arstesanai

Info

Publication number
LV10191A
LV10191A LV930231A LV930231A LV10191A LV 10191 A LV10191 A LV 10191A LV 930231 A LV930231 A LV 930231A LV 930231 A LV930231 A LV 930231A LV 10191 A LV10191 A LV 10191A
Authority
LV
Latvia
Prior art keywords
hepatitis
pharmaceuticals
infections
virus
treatment
Prior art date
Application number
LV930231A
Other languages
English (en)
Other versions
LV10191B (en
Inventor
Dennis W Adair
Kenneth A Smiles
Original Assignee
Oclassen Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oclassen Pharma Inc filed Critical Oclassen Pharma Inc
Publication of LV10191A publication Critical patent/LV10191A/lv
Publication of LV10191B publication Critical patent/LV10191B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
LVP-93-231A 1992-04-06 1993-04-06 Compositions for the treatment of infection and disease caused by hepatitis b virus (hbv) LV10191B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US86389092A 1992-04-06 1992-04-06
US95292792A 1992-09-25 1992-09-25
US07/959,004 US5432165A (en) 1992-04-06 1992-10-09 Methods for the treatment of infection caused by Hepatitis B virus (HBV)

Publications (2)

Publication Number Publication Date
LV10191A true LV10191A (lv) 1994-10-20
LV10191B LV10191B (en) 1995-04-20

Family

ID=27420427

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-93-231A LV10191B (en) 1992-04-06 1993-04-06 Compositions for the treatment of infection and disease caused by hepatitis b virus (hbv)

Country Status (26)

Country Link
US (1) US5432165A (lv)
EP (1) EP0565412A1 (lv)
JP (1) JPH069403A (lv)
CN (1) CN1081879A (lv)
AP (1) AP372A (lv)
AU (1) AU662804B2 (lv)
BE (1) BE1009181A5 (lv)
BR (1) BR9306207A (lv)
CA (1) CA2092356A1 (lv)
EE (1) EE9400068A (lv)
ES (1) ES2105923B1 (lv)
FR (1) FR2689398B1 (lv)
GR (1) GR930100111A (lv)
IL (1) IL105169A0 (lv)
IT (1) IT1264332B1 (lv)
LV (1) LV10191B (lv)
MD (1) MD940152A (lv)
MX (1) MX9301922A (lv)
NO (1) NO931246L (lv)
NZ (1) NZ247188A (lv)
OA (1) OA10102A (lv)
PH (1) PH31116A (lv)
PT (1) PT101238A (lv)
SI (1) SI9300144A (lv)
WO (1) WO1993019762A1 (lv)
YU (1) YU23993A (lv)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6346627B1 (en) 1990-02-01 2002-02-12 Emory University Intermediates in the synthesis of 1,3-oxathiolane nucleoside enantiomers
US5444063A (en) * 1990-12-05 1995-08-22 Emory University Enantiomerically pure β-D-dioxolane nucleosides with selective anti-Hepatitis B virus activity
US6200952B1 (en) * 1993-06-02 2001-03-13 Sciclone Pharmaceuticals, Inc. Combination therapy method for treating chronic hepatitis B
US5587362A (en) * 1994-01-28 1996-12-24 Univ. Of Ga Research Foundation L-nucleosides
WO1996010649A1 (en) * 1994-09-30 1996-04-11 Southwest Foundation For Biomedical Research Isolated human hepatitis b virus polymerase and uses thereof
US5703058A (en) * 1995-01-27 1997-12-30 Emory University Compositions containing 5-fluoro-2',3'-didehydro-2',3'-dideoxycytidine or a mono-, di-, or triphosphate thereof and a second antiviral agent
US6391859B1 (en) 1995-01-27 2002-05-21 Emory University [5-Carboxamido or 5-fluoro]-[2′,3′-unsaturated or 3′-modified]-pyrimidine nucleosides
US5808040A (en) * 1995-01-30 1998-09-15 Yale University L-nucleosides incorporated into polymeric structure for stabilization of oligonucleotides
US6296882B1 (en) * 2000-06-12 2001-10-02 Manuel Viamonte, Jr. Non-toxic mucosal disinfectant containing isopropyl alcohol, sesame oil, and lemon oil
US8076303B2 (en) 2005-12-13 2011-12-13 Spring Bank Pharmaceuticals, Inc. Nucleotide and oligonucleotide prodrugs
JP2012526149A (ja) * 2009-05-08 2012-10-25 サイクローン・ファーマシューティカルズ・インコーポレイテッド ワクチン増強剤としてのαチモシンペプチド

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE147774C (lv) *
US4211773A (en) * 1978-10-02 1980-07-08 Sloan Kettering Institute For Cancer Research 5-Substituted 1-(2'-Deoxy-2'-substituted-β-D-arabinofuranosyl)pyrimidine nucleosides
US4594339A (en) * 1982-04-06 1986-06-10 Sloan-Kettering Institute For Cancer Research Anti-herpes virus compositions containing 5-substituted 1-2'(deoxy-2-'-substituted-β-d-arabinofuranosyl)pyrimedene nucleosides
US4666892A (en) * 1984-03-06 1987-05-19 Sloan-Kettering Memorial Cancer Center Method and composition for hepatitis treatment with pyrimidine nucleoside compounds

Also Published As

Publication number Publication date
PT101238A (pt) 1994-03-31
IT1264332B1 (it) 1996-09-23
EP0565412A1 (en) 1993-10-13
WO1993019762A1 (en) 1993-10-14
MD940152A (ro) 1995-12-31
IL105169A0 (en) 1993-07-08
FR2689398A1 (fr) 1993-10-08
ES2105923A1 (es) 1997-10-16
SI9300144A (en) 1994-03-31
ITTO930226A1 (it) 1994-10-05
ITTO930226A0 (it) 1993-04-05
ES2105923B1 (es) 1998-07-01
AU3530293A (en) 1993-10-07
NO931246D0 (no) 1993-03-31
BE1009181A5 (fr) 1996-12-03
EE9400068A (et) 1995-12-15
US5432165A (en) 1995-07-11
AU662804B2 (en) 1995-09-14
CA2092356A1 (en) 1993-10-07
JPH069403A (ja) 1994-01-18
NO931246L (no) 1993-10-07
BR9306207A (pt) 1998-06-23
YU23993A (sh) 1997-05-28
AP9300513A0 (en) 1993-04-30
CN1081879A (zh) 1994-02-16
GR930100111A (el) 1993-12-30
MX9301922A (es) 1993-10-01
PH31116A (en) 1998-02-28
LV10191B (en) 1995-04-20
AP372A (en) 1994-11-24
NZ247188A (en) 1995-05-26
FR2689398B1 (fr) 1994-11-18
OA10102A (en) 1996-12-18

Similar Documents

Publication Publication Date Title
ITMI931522A1 (it) Composizione farmaceutiche per il trattamento dell'infezione da virus dell'epatite b (hbv)
NO924461D0 (no) Dipyridamol for behandling av proliferaktive sykdommer
MX9101046A (es) Anticuerpos novedosos para el tratamiento y prevencion de infeccion de animales y el hombre
BR9305077A (pt) Seringa hipodémica
MX9202839A (es) 4-aminoquinolinas y composiciones farmaceuticas de las mismas.
NO930677L (no) Farmasoeytiske forbindelser
DK19893D0 (da) Praeparat til nasal behandling
LV10191A (lv) Farmaceitiski lidzekli hepatita B virusa izraisito infekciju un slimibu arstesanai
NO940810D0 (no) Behandling av virusinfeksjoner
BR9302433A (pt) Composto,composicao farmaceutica,processos para tratar infeccoes virais e neoplasmas
NO931008D0 (no) Farmasoeytiske forbindelser
DE69309570T2 (de) Spritze
FI944561A0 (fi) HIV:tä neutraloivia monoklonaalisia yhdistelmähumaanivasta-aineita HIV-infektion ehkäisemiseksi ja hoitamiseksi
DE69004451T2 (de) Prophylaxe und Behandlung von Herpesvirus-Infektionen.
NO951995D0 (no) Kombinasjon av atovaquon med proguantil for behandling av protozoinfeksjoner
KR950700737A (ko) 기도 염증 및 기도 과잉반응의 치료약품(Medicament for the treatment of airways inflammation and airways hyperresponsiveness)
IL102815A0 (en) Pharmaceutical compositions and method for the treatment of infection caused by the human immunodeficiency virus
EP0655919A4 (en) TREATMENT OF VIRAL INFECTIONS IN MAN.
LTIP472A (en) Composition for the treatment of infection and disease caused by hepatit b virus
NO960551D0 (no) Antistoff basert behandling av HIV infeksjon
NO930550L (no) Metode og preparat for behandling av virale infeksjoner
EE9500019A (et) Farmatseutiline kompositsioon viirusliku infektsiooni ja neoplasma raviks
DE59405654D1 (de) T-lymphozyten enthaltende pharmazeutische zusammensetzung zur behandlung von infektionen
NO920039L (no) Farmasoeytiske preparater
DK8893A (da) Medikament til behandling eller forebyggelse af sygdom